# Arcturus Therapeutics Holdings Inc.: Form 8-K, filed Nov 4, 2022

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: 8-K
- Filed: 2022-11-04
- Accepted by EDGAR: Nov 4, 2022, 17:00 ET
- Period: 2022-10-31
- Accession: 0001193805-22-001480
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380522001480/e617791_8k-arcturus.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380522001480/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380522001480/e617791_8k-arcturus.htm

Filed Nov 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001193805-22-001480. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
